Samuel Horr, MD
Interventional Cardiology · Nashville, TNNPI 1417273061
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Edwards Lifesciences at 24.7% of the total. 2025 is the largest year on record at $78,152, 8.3 times the $9,452 reported in 2019. Among interventional cardiology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 597 payments — averaging $412.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$61K
- Abbott$54K
- Inari Medical, Inc.$51K
- Inquis Medical, Inc.$34K
- Boston Scientific$17K
- Stryker$16K
- plus $12K from 28 others
Across 443 payments — averaging $1503.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$308K
- Abbott$196K
- Boston Scientific$98K
- Stryker$49K
- Edwards Lifesciences$15K
What the payments were for
- Consulting fees$129,97553%
- Speaking & faculty fees$64,68026%
- Grants$2220%
- Travel & lodging$27,10511%
- Food & beverage$24,33210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 129 | $60,752 |
| Abbott | 128 | $54,489 |
| Inari Medical, Inc. | 65 | $50,996 |
| Inquis Medical, Inc. | 25 | $34,163 |
| Boston Scientific | 119 | $17,333 |
| Stryker | 12 | $16,464 |
| Abiomed | 8 | $3,516 |
| Penumbra, Inc. | 10 | $2,554 |
| Biosense Webster, Inc. | 5 | $1,312 |
| Medtronic(2 entities) | 16 | $1,100 |
| Cardiva Medical, Inc. | 6 | $890 |
| Endovascular Engineering Inc. | 1 | $500 |
| Opsens Inc. | 5 | $475 |
| Shockwave Medical, Inc | 16 | $460 |
| Pfizer | 17 | $274 |
| Johnson & Johnson | 3 | $150 |
| AstraZeneca | 3 | $115 |
| Biolife, L.L.C. | 1 | $110 |
| EKOS Corporation | 2 | $103 |
| Spectrawave, Inc | 3 | $93 |
| Novo Nordisk | 3 | $74 |
| Imperative Care, Inc | 1 | $58 |
| Cardiac Dimensions, Inc. | 2 | $50 |
| Amgen | 3 | $44 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $37 |
| E.r. Squibb & Sons, L.L.C. | 1 | $35 |
| Novartis | 2 | $26 |
| Thrombolex, Inc. | 1 | $25 |
| Bridgebio Pharma, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $20 |
| Heartflow, Inc. | 1 | $20 |
| Philips North America LLC | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$65,973
- FLOWTRIEVER CATHETER, S$65,783
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$43,118
- Aventus$33,798
- TRICLIP$14,501
- Mitra Clip system$12,379
- GENERAL - THERAPIES$10,890
- MitraClip$5,667
- Impella$3,332
- Edwards SAPIEN 3 Transcatheter Heart Valve$3,136
- Indigo System$2,400
- MitraClip System$2,000
- SavvyWire$2,000
- TENDYNE$2,000
- Tricuspid Valve Repair System$1,781
- THERMOCOOL SMARTTOUCH$982
- SAPIEN 3 Ultra RESILIA$874
- Tendyne Mitral Valve System$652
- WATCHMAN Access System$640
- STINGRAY$500
How this compares
$246,315 in reported general payments places this provider in the 95th percentile of 207 interventional cardiology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 61 | $56,901 |
| XareltoRivaroxaban | 27 | $20,657 |
| EntrestoSacubitril/Valsartan | 16 | $13,177 |
| Metoprolol Succinate | 60 | $991 |
| Atorvastatin Calcium | 100 | $976 |
| Flecainide Acetate | 11 | $670 |
| ClopidogrelClopidogrel Bisulfate | 67 | $630 |
| Spironolactone | 35 | $377 |
| Ezetimibe | 13 | $359 |
| Carvedilol | 44 | $348 |
| Lisinopril | 32 | $273 |
| Losartan Potassium | 25 | $227 |
| Torsemide | 12 | $181 |
| Amlodipine Besylate | 55 | $180 |
| Rosuvastatin Calcium | 20 | $180 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $274 | $56,90161 claims |
| Johnson & JohnsonXarelto | $150 | $20,65727 claims |
| NovartisEntresto | $26 | $13,17716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 207 interventional cardiology providers in Tennessee.
Other interventional cardiology in Nashville
- Jimmy KerriganNashville$644K
- Kashish GoelNashville$558K
- Brian JeffersonNashville$547K
- Michael MorseNashville$353K
- Nadia SuttonNashville$344K
- Colin BarkerNashville$217K
- Leah RajNashville$88K
- Andrew GoodmanNashville$57K
- Jay PatelNashville$48K
- John RiddickNashville$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.